NIAMS Clinical Trial Implementation Cooperative Agreement
Funds a two-phase cooperative agreement to prepare for, then run, a clinical trial in arthritis, musculoskeletal or skin disease.
Plenty of trials are designed and never get past the practical work of actually starting one — sites signed, boards cleared, staff hired. NIAMS funds that step explicitly, then funds running the trial itself, as one award.
The mechanism supports investigator-initiated, single- or multi-site interventional clinical trials, at any phase, inside NIAMS's mission: arthritis and rheumatic disease, musc…
Cooperative agreement support for investigator-initiated, single- or multi-site interventional clinical trials, all phases, within the National Institute of Arthritis and Musculoskeletal and Skin Diseases' mission — for investigators who have already completed trial design, protocol synopsis and data analysis plan through other means. Structured in two phases: preparing the single IRB, site contracts and staffing, then running the trial, with transition to phase two dependent on meeting phase one's milestones. A clinical trial is required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up